Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997 Jan-Mar;3(1):33-9.
doi: 10.3201/eid0301.970104.

Fluoroquinolone resistance in Neisseria gonorrhoeae

J S Knapp  1 , K K Fox, D L Trees, W L Whittington
Affiliations
Review

Fluoroquinolone resistance in Neisseria gonorrhoeae

J S Knapp et al. Emerg Infect Dis. 1997 Jan-Mar.

Erratum in

  • Emerg Infect Dis 1997 Oct-Dec;3(4):584

Abstract

Fluoroquinolones and broad-spectrum cephalosporins are the most effective antimicrobial agents for the treatment of gonorrhea. However, clinically significant resistance to fluoroquinolones has emerged in Neisseria gonorrhoeae. Fluoroquinolone-resistant strains account for approximately 10% of all gonococcal strains in Hong Kong and the Republic of the Philippines. As many as 50% of strains from some Far Eastern countries exhibit decreased susceptibility (intermediate resistance) to fluoroquinolones. Strains with intermediate resistance and clinically significant resistance are being isolated sporadically in North America, where resistant strains have been associated with an outbreak and with failure of infections to respond to treatment with doses of ciprofloxacin and ofloxacin recommended by the Centers for Disease Control and Prevention; strains exhibiting decreased susceptibility to these agents are endemic in at least one metropolitan area. Monitoring for fluoroquinolone resistance is now critical for ensuring adequate treatment of infections with resistant strains and for maximizing the time during which fluoroquinolones may be used to treat gonorrhea.

PubMed Disclaimer

References

    1. Mol Microbiol. 1994 Oct;14(2):371-80 - PubMed
    1. Antimicrob Agents Chemother. 1994 Sep;38(9):2200-3 - PubMed
    1. MMWR Morb Mortal Wkly Rep. 1995 Oct 20;44(41):761-4 - PubMed
    1. Antimicrob Agents Chemother. 1995 Oct;39(10):2367-70 - PubMed
    1. Antimicrob Agents Chemother. 1995 Nov;39(11):2442-5 - PubMed